At the end of the latest market close, Rigel Pharmaceuticals Inc. (RIGL) was valued at $2.56. In that particular session, Stock kicked-off at the price of $2.54 while reaching the peak value of $2.59 and lowest value recorded on the day was $2.39. The stock current value is $2.39.Recently in News on January 10, 2022, Rigel to Present at the J.P. Morgan Healthcare Conference. Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company’s president and chief executive officer, is scheduled to present a company overview at the 40th Annual J.P. Morgan Healthcare Conference at 10:30 a.m. ET on Wednesday, January 12, 2022. You can read further details here
Rigel Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.75 on 01/03/22, with the lowest value was $2.37 for the same time period, recorded on 01/10/22.
Rigel Pharmaceuticals Inc. (RIGL) full year performance was -36.27%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Rigel Pharmaceuticals Inc. shares are logging -56.55% during the 52-week period from high price, and 3.91% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.30 and $5.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1348974 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Rigel Pharmaceuticals Inc. (RIGL) recorded performance in the market was -9.81%, having the revenues showcasing -31.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 424.89M, as it employees total of 169 workers.
The Analysts eye on Rigel Pharmaceuticals Inc. (RIGL)
During the last month, 0 analysts gave the Rigel Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.21, with a change in the price was noted -1.26. In a similar fashion, Rigel Pharmaceuticals Inc. posted a movement of -34.52% for the period of last 100 days, recording 1,433,857 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RIGL is recording 0.40 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.40.
Technical rundown of Rigel Pharmaceuticals Inc. (RIGL)
Raw Stochastic average of Rigel Pharmaceuticals Inc. in the period of last 50 days is set at 6.92%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.17%. In the last 20 days, the company’s Stochastic %K was 28.12% and its Stochastic %D was recorded 34.82%.
Considering, the past performance of Rigel Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.81%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -41.56%, alongside a downfall of -36.27% for the period of the last 12 months. The shares increased approximately by -2.05% in the 7-day charts and went down by 0.00% in the period of the last 30 days. Common stock shares were lifted by -31.71% during last recorded quarter.